PART I Overview For three decades, we have invented medicines that bring better futures to people with serious diseases. As a pioneer in RNA-targeted medicines with a deep understanding of disease biology and an industry-leading drug discovery technology, we are driven to deliver innovative, life-changing advances for patients. In the last year, we delivered on our strategy to create accelerating value for all our stakeholders. With two independent commercial launches now underway, we transition...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0000874015-26-000115 | EDGAR | 90K words |
| 2025-02-19 | 2024-12-31 | 0000874015-25-000089 | EDGAR | — |
| 2024-02-21 | 2023-12-31 | 0000874015-24-000116 | EDGAR | — |
| 2023-02-22 | 2022-12-31 | 0000874015-23-000105 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0000874015-22-000079 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0000874015-21-000056 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001140361-20-004500 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-29 | 2025-09-30 | 0000874015-25-000266 | EDGAR | 38K words |
| 2025-07-30 | 2025-06-30 | 0000874015-25-000167 | EDGAR | — |
| 2025-04-30 | 2025-03-31 | 0000874015-25-000123 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000874015-24-000232 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000874015-24-000187 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000874015-24-000142 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000874015-23-000209 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000874015-23-000186 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000874015-23-000136 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000874015-22-000168 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000874015-22-000148 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0000874015-22-000104 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-09 | 0001140361-26-008340 | EDGAR | 1K words |
| 2026-02-25 | 0001140361-26-006718 | EDGAR | — |
| 2026-01-12 | 0001140361-26-000893 | EDGAR | — |
| 2026-01-07 | 0001140361-26-000435 | EDGAR | — |
| 2025-11-17 | 0001193125-25-284609 | EDGAR | — |
| 2025-11-10 | 0001140361-25-041225 | EDGAR | — |
| 2025-10-29 | 0001140361-25-039650 | EDGAR | — |
| 2025-09-22 | 0001140361-25-035634 | EDGAR | — |
| 2025-09-02 | 0001140361-25-033541 | EDGAR | — |
| 2025-08-21 | 0001140361-25-032176 | EDGAR | — |
128 total filings indexed. 99 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000874015 |
| Ticker | IONS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | CA |
| Website | https://www.ionis.com |
| Listed | 1991-05-17 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report